The HIV fusion inhibitor, enfuviide, acts at the site of:
ENFUVIIDE: This HIV derived synthetic peptide acts by binding to HIV-1 envelope transmembrane glycoprotein(gp 41) which is involved in fusion of viral and cellular membranes. ESSENTIALS OF MEDICAL PHARMACOLOGY K.D.TRIPATHI SEVENTH EDITION PAGE NO:811
Gp 120
Gp 41
P24
CXCR4
Chemotherapy